A detailed history of Hartford Investment Management CO transactions in Moderna, Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 21,115 shares of MRNA stock, worth $778,087. This represents 0.05% of its overall portfolio holdings.

Number of Shares
21,115
Previous 21,362 1.16%
Holding current value
$778,087
Previous $2.54 Million 44.36%
% of portfolio
0.05%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$63.64 - $125.14 $15,719 - $30,909
-247 Reduced 1.16%
21,115 $1.41 Million
Q2 2024

Aug 01, 2024

SELL
$101.21 - $166.61 $8,096 - $13,328
-80 Reduced 0.37%
21,362 $2.54 Million
Q1 2024

Apr 17, 2024

SELL
$85.37 - $115.44 $78,369 - $105,973
-918 Reduced 4.11%
21,442 $2.28 Million
Q4 2023

Jan 23, 2024

SELL
$69.51 - $104.43 $14,805 - $22,243
-213 Reduced 0.94%
22,360 $2.22 Million
Q3 2023

Oct 16, 2023

SELL
$96.41 - $126.61 $41,167 - $54,062
-427 Reduced 1.86%
22,573 $2.33 Million
Q2 2023

Jul 19, 2023

SELL
$118.5 - $160.53 $571,288 - $773,915
-4,821 Reduced 17.33%
23,000 $2.79 Million
Q1 2023

May 09, 2023

BUY
$135.66 - $197.02 $531,651 - $772,121
3,919 Added 16.4%
27,821 $4.27 Million
Q4 2022

Jan 20, 2023

SELL
$118.38 - $210.04 $951,538 - $1.69 Million
-8,038 Reduced 25.17%
23,902 $4.29 Million
Q3 2022

Nov 02, 2022

SELL
$118.07 - $194.18 $140,857 - $231,656
-1,193 Reduced 3.6%
31,940 $3.78 Million
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $124,509 - $187,715
-1,063 Reduced 3.11%
33,133 $4.73 Million
Q1 2022

Apr 20, 2022

SELL
$126.46 - $235.05 $311,597 - $579,163
-2,464 Reduced 6.72%
34,196 $5.89 Million
Q4 2021

Feb 02, 2022

BUY
$225.82 - $368.51 $676,556 - $1.1 Million
2,996 Added 8.9%
36,660 $9.31 Million
Q3 2021

Nov 01, 2021

BUY
$221.9 - $484.47 $7.47 Million - $16.3 Million
33,664 New
33,664 $13 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.